Perbedaan Organon Pharma Indonesia Tbk. dan Semen Indonesia (Persero) Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Semen Indonesia (Persero) Tbk. diperdagangkan di Rp1.695 (kapitalisasi pasar 11,68 T, volume 24 jam 20,89 jt). Perbedaan utamanya: Semen Indonesia (Persero) Tbk. jauh lebih besar — sekitar 111,9× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SMGR | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 11,68 T |
Volume | — | 20,89 jt |
Lot | — | 208,88 rb |
Perputaran | — | 35,38 M |
Harga Rata-rata | — | 1.693,71 |
Nilai Transaksi | — | 35,38 M |
Harga Ekuilibrium Indikatif | — | 1.695 |
Volume Ekuilibrium Indikatif | — | 10,02 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Semen Indonesia (Persero) Tbk was established on March 25,1953 as NV Pabrik Semen Gresik. On April 17, 1961,NV Pabrik Semen Gresik was transformed into a state enterprise (Persero) by Government Regulation No. 132 year 1961, and subsequently became PT Semen Gresik (Persero). Semen Gresik is a cement producer which was formerly fully owned by the government. On July 1995 the company shareholders meeting agreed to acquired 100% share of two state owned cement producer companies, namely PT. Semen Tonasa and PT. Semen Padang.
Selengkapnya di halaman SMGR →